# Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy

> **NCT02633930** · PHASE4 · COMPLETED · sponsor: **Xijing Hospital of Digestive Diseases** · enrollment: 566 (actual)

## Conditions studied

- Gastritis
- Peptic Ulcer
- Dyspepsia

## Interventions

- **DRUG:** Berberine
- **DRUG:** clarithromycin
- **DRUG:** Bismuth
- **DRUG:** Lansoprazole
- **DRUG:** amoxicillin

## Key facts

- **NCT ID:** NCT02633930
- **Lead sponsor:** Xijing Hospital of Digestive Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-06
- **Final completion:** 2016-08
- **Target enrollment:** 566 (ACTUAL)
- **Last updated:** 2017-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02633930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02633930, "Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02633930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*